Trials / Completed
CompletedNCT04509089
Establishing Correlation Between Non-invasive Pulmonary Blood Pressure Readings and Swan-Ganz Results
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Suremedix Ltd · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Pulmonary hypertension (PH) is prognostic indicator in heart failure patients for poor outcome, however, it is challenging for monitoring. The current study is designed to explore whether data generated using Suremedix Device including a pump and non-invasive sensors including, chest motion sensor, photoplethysmography (PPG), and Electrocardiography (ECG), can be used to identify detectable oscillations that are correlated with the mean, the diastolic and the systolic pressure values of the pulmonary artery, as measured using the gold-standard Swan-Ganz method.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Suremedix Device | Performing measurements using the Suremedix Device by applying gradually ascending air pressure to the subject lungs through a mouse piece while measuring respiratory chest motion, PPG and ECG. |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2021-01-29
- Completion
- 2021-03-01
- First posted
- 2020-08-11
- Last updated
- 2021-08-04
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT04509089. Inclusion in this directory is not an endorsement.